Skip to main content

Navigation Navigation

Web Content Display Web Content Display

Seminar „Between physics, biology and medicine”

The seminar „Between physics, biology and medicine” is dedicated to the presentation of the latest achievements and research in the field of biophysics and medical physics. The hosts of the seminar are prof. Ewa Ł. Stępień, the head of the Department of Medical Physics, and prof. Paweł Moskal, the head of the Department of Experimental Particle Physics and Applications. The seminar is organized regularly every other Wednesday at 16:15 in lecture hall A-1-08.

The speakers of the seminar are invited guests from polish and foreign universities, our collaborators, scientists interested in application of physics in medical and biological research.

Past seminars

Web Content Display Web Content Display

Prof. dr hab. Aleksander Bilewicz (Institute of Nuclear Chemistry and Technology, Warsaw, Poland)

event-date: 21.01.2020

Title:
"Short range particles emitters in radionuclide therapy"

January 21, A-1-08. Speaker:  Prof. Aleksander Bilewicz (Institute of Nuclear Chemistry and Technology, Warsaw).

Curriculum vitae of the speaker

Announcement about the seminar
 

Abstract

Currently, the most important problem in oncology is the effective treatment of tiny clusters of tumor cells, micrometastases or even single cancer cells. In this case spectacular therapeutic results are achieved recently with use of the targeting molecules labeled with the emitters of short distance corpuscular radiation like α and Auger electron particles which are well suited for this purpose because of their inherent high energy and short range, contributing to their high LET and radiobiologic effectiveness.

In the first part of the lecture new radiopharmaceuticals based on α emitters will be presented. Particular attention will be paid to various concepts of radionuclides binding to biologically active molecules, properties of obtained radiopharmaceuticals and the first results of their application in clinical trials.

In the second part of the lecture, the studies on radiopharmaceuticals labelled with Auger emitters, which are currently being carried out at the Institute of Nuclear Chemistry and Technology in Warsaw will be discussed. At the end the concept of application 195mPt labelled platinum nanoparticles in hepatocellular carcinoma (HepG2) treatment will be presented.

Back

Published Date: 07.01.2020
Published by: Tomasz Malarz